Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study.
Christian Kelly-MorlandSarah RudmanPaul NathanSusan MallettGiovanni MontanaGary CookVicky GohPublished in: BMC cancer (2017)
The trial is approved by the Southeast London Research Ethics Committee reference 16/LO/1499 and registered on the NIHR clinical research network portfolio ISRCTN12114913 .
Keyphrases
- positron emission tomography
- computed tomography
- magnetic resonance imaging
- contrast enhanced
- pet ct
- pet imaging
- papillary thyroid
- small cell lung cancer
- single cell
- public health
- clinical trial
- study protocol
- phase iii
- diffusion weighted imaging
- big data
- squamous cell
- randomized controlled trial
- young adults
- bone marrow
- machine learning
- mesenchymal stem cells
- childhood cancer
- network analysis